US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

NEUROONE MEDICAL TECH

0.5890

+0.00731.25%

Post-market: 0.5620-0.0270-4.58%19:45 EDT

Volume:109.93K

Turnover:63.62K

Market Cap:29.34M

PE:-2.33

High:0.5954

Open:0.5820

Low:0.5620

Close:0.5817

Loading ...

Overview Company News Filings

Mark Christianson, Business Development Director, Reports Disposal of Common Shares in Neuroone Medical Technologies Corporation

Neuroone Medical Technologies Corp Files Initial Beneficial Ownership Statement for Emily Johns, General Counsel

Neuroone Strengthens Leadership Team With Appointment of Emily Johns as General Counsel and Corporate Secretary

THOMSON REUTERS

Mark Christianson, Business Development Director, Reports Disposal of Neuroone Medical Technologies Corp Common Shares

Neuroone Medical Technologies Corp Officer Mark Christianson Reports Disposal of Common Shares

NeuroOne Medical Tech Q2 EPS $(0.07) Up From $(0.11) YoY, Sales $1.39M Beat $1.27M Estimate

Neuroone Medical Technologies Corp: Q2 Product Revenue $1.4 Mln

THOMSON REUTERS

Neuroone Medical Technologies Corp: Q2 Shr Loss $0.07

THOMSON REUTERS

Neuroone® Reports Second Quarter Fiscal Year 2025 Financial Results; Gross Margin Improves Significantly YoY to 55.6%

THOMSON REUTERS

Neuroone Medical Technologies Corp - Reaffirms FY 2025 Product Revenue Guidance of $8-$10 Mln

THOMSON REUTERS

NeuroOne Medical Technologies Faces Nasdaq Delisting Risk Due to Stock Price Non-Compliance

NeuroOne Medical Announces Participation in The D. Boral Capital Inaugural Global Conference

NeuroOne Medical Tech Initiated at Buy by Ladenburg Thalmann

NeuroOne Medical initiated with a Buy at Ladenburg

Small Business Owners Are Not as Financially Prepared as They May Think, According to TD Bank Survey

Apogee Enterprises Reports Fiscal 2025 Fourth Quarter and Full Year Results

Neuroone® Completes FDA Submission for the Onerf® Trigeminal Nerve Ablation System to Treat Facial Pain

THOMSON REUTERS

NeuroOne® Completes FDA Submission for the OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain

NeuroOne Medical Technologies Corp (NMTC) Q1 2025 Earnings Call Highlights: Regulatory Success ...

BRIEF-Neuroone Medical Technologies Corp -Company Now Fully Funded Through At Least Fiscal 2026

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/NMTC/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NMTC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NMTC\",,,,,undefined,":{"symbol":"NMTC","market":"US","secType":"STK","nameCN":"NEUROONE MEDICAL TECH","latestPrice":0.589,"timestamp":1749499200000,"preClose":0.5817,"halted":0,"volume":109928,"hourTrading":{"tag":"盘后","latestPrice":0.562,"preClose":0.589,"latestTime":"19:45 EDT","volume":3081,"amount":1734.1801,"timestamp":1749512757016},"delay":0,"floatShares":46155700,"shares":49817835,"eps":-0.252446,"marketStatus":"Not Yet Opened","change":0.0073,"latestTime":"06-09 16:00:00 EDT","open":0.582,"high":0.5954,"low":0.562,"amount":63624.1608184,"amplitude":0.057418,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.252446,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1749542400000},"marketStatusCode":0,"adr":0,"exchange":"NASDAQ","adjPreClose":0.5817,"preHourTrading":{"tag":"盘前","latestPrice":0.562,"preClose":0.5817,"latestTime":"09:29 EDT","volume":369,"amount":207.22397940000002,"timestamp":1749475794529},"postHourTrading":{"tag":"盘后","latestPrice":0.562,"preClose":0.589,"latestTime":"19:45 EDT","volume":3081,"amount":1734.1801,"timestamp":1749512757016},"volumeRatio":0.463944,"impliedVol":1.4254,"impliedVolPercentile":0.372},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NMTC\",,,,,undefined,":{"symbol":"NMTC","floatShares":46155700,"roa":"-83.48%","roe":"-265.18%","lyrEps":-0.460276,"volumeRatio":0.463944,"shares":49817835,"dividePrice":0,"high":0.5954,"amplitude":0.057418,"preClose":0.5817,"low":0.562,"week52Low":0.3954,"pbRate":"26.06","psRate":"5.10","week52High":1.39,"institutionHeld":0,"latestPrice":0.589,"eps":-0.252446,"divideRate":0,"volume":109928,"delay":0,"ttmEps":-0.252446,"open":0.582,"prevYearClose":0.8259,"prevWeekClose":0.5817,"prevMonthClose":0.6111,"prevQuarterClose":0.8502,"fiveDayClose":0.5929,"twentyDayClose":0.6152,"sixtyDayClose":1.02},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NMTC\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2541005395","title":"Mark Christianson, Business Development Director, Reports Disposal of Common Shares in Neuroone Medical Technologies Corporation","url":"https://stock-news.laohu8.com/highlight/detail?id=2541005395","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541005395?lang=en_us&edition=fundamental","pubTime":"2025-06-06 04:09","pubTimestamp":1749154143,"startTime":"0","endTime":"0","summary":"Mark Christianson, Business Development Director, Reports Disposal of Common Shares in Neuroone Medical Technologies Corporation. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neuroone Medical Technologies Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 05, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250605:nNDL4PFr2B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Mark Christianson, Business Development Director, Reports Disposal of Common Shares in Neuroone Medical Technologies Corporation","news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","NMTC"],"gpt_icon":0},{"id":"2540701744","title":"Neuroone Medical Technologies Corp Files Initial Beneficial Ownership Statement for Emily Johns, General Counsel","url":"https://stock-news.laohu8.com/highlight/detail?id=2540701744","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540701744?lang=en_us&edition=fundamental","pubTime":"2025-06-04 03:38","pubTimestamp":1748979511,"startTime":"0","endTime":"0","summary":"Neuroone Medical Technologies Corporation has filed an initial statement of beneficial ownership. The filing mentions Emily Johns as the beneficial owner, who holds the role of General Counsel at the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neuroone Medical Technologies Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 03, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250603:nNDL3ZGwV1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NMTC","BK4082"],"gpt_icon":0},{"id":"2540777164","title":"Neuroone Strengthens Leadership Team With Appointment of Emily Johns as General Counsel and Corporate Secretary","url":"https://stock-news.laohu8.com/highlight/detail?id=2540777164","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540777164?lang=en_us&edition=fundamental","pubTime":"2025-06-03 20:30","pubTimestamp":1748953800,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250603:nTUA7BGLXL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","NMTC"],"gpt_icon":0},{"id":"2537154106","title":"Mark Christianson, Business Development Director, Reports Disposal of Neuroone Medical Technologies Corp Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2537154106","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537154106?lang=en_us&edition=fundamental","pubTime":"2025-05-24 04:04","pubTimestamp":1748030653,"startTime":"0","endTime":"0","summary":"Mark Christianson, Business Development Director at Neuroone Medical Technologies Corporation, reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neuroone Medical Technologies Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 23, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250523:nNDL3qkcvw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Mark Christianson, Business Development Director, Reports Disposal of Neuroone Medical Technologies Corp Common Shares","news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NMTC","BK4082"],"gpt_icon":0},{"id":"2537659959","title":"Neuroone Medical Technologies Corp Officer Mark Christianson Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2537659959","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537659959?lang=en_us&edition=fundamental","pubTime":"2025-05-22 04:15","pubTimestamp":1747858525,"startTime":"0","endTime":"0","summary":"Mark Christianson, the Business Development Director at Neuroone Medical Technologies Corporation, reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neuroone Medical Technologies Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 21, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250521:nNDL5gSl8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NMTC","BK4082"],"gpt_icon":0},{"id":"2535721228","title":"NeuroOne Medical Tech Q2 EPS $(0.07) Up From $(0.11) YoY, Sales $1.39M Beat $1.27M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2535721228","media":"Benzinga","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535721228?lang=en_us&edition=fundamental","pubTime":"2025-05-13 19:31","pubTimestamp":1747135912,"startTime":"0","endTime":"0","summary":"NeuroOne Medical Tech (NASDAQ:NMTC) reported quarterly losses of $(0.07) per share. This is a 36.36 percent increase over losses of $(0.11) per share from the same period last year.  The company reported quarterly sales","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45371937/neuroone-medical-tech-q2-eps-0-07-up-from-0-11-yoy-sales-1-39m-beat-1-27m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NMTC"],"gpt_icon":0},{"id":"2535802724","title":"Neuroone Medical Technologies Corp: Q2 Product Revenue $1.4 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2535802724","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535802724?lang=en_us&edition=fundamental","pubTime":"2025-05-13 19:30","pubTimestamp":1747135801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250513:nTUA8RC958:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NMTC","BK4082"],"gpt_icon":0},{"id":"2535724884","title":"Neuroone Medical Technologies Corp:  Q2 Shr Loss $0.07","url":"https://stock-news.laohu8.com/highlight/detail?id=2535724884","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535724884?lang=en_us&edition=fundamental","pubTime":"2025-05-13 19:30","pubTimestamp":1747135801,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250513:nTUA8RC958:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","NMTC"],"gpt_icon":0},{"id":"2535721432","title":"Neuroone® Reports Second Quarter Fiscal Year 2025 Financial Results; Gross Margin Improves Significantly YoY to 55.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535721432","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535721432?lang=en_us&edition=fundamental","pubTime":"2025-05-13 19:30","pubTimestamp":1747135801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250513:nTUA8RC958:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","NMTC"],"gpt_icon":0},{"id":"2535217827","title":"Neuroone Medical Technologies Corp - Reaffirms FY 2025 Product Revenue Guidance of $8-$10 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2535217827","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535217827?lang=en_us&edition=fundamental","pubTime":"2025-05-13 19:30","pubTimestamp":1747135801,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250513:nTUA8RC958:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NMTC","BK4082"],"gpt_icon":0},{"id":"2534466696","title":"NeuroOne Medical Technologies Faces Nasdaq Delisting Risk Due to Stock Price Non-Compliance","url":"https://stock-news.laohu8.com/highlight/detail?id=2534466696","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534466696?lang=en_us&edition=fundamental","pubTime":"2025-05-10 04:30","pubTimestamp":1746822654,"startTime":"0","endTime":"0","summary":"NeuroOne Medical Technologies Corporation has announced that it received a notification from the Nasdaq Stock Market indicating a failure to meet the minimum bid price requirement for continued listing. The company's common stock has had a closing bid price below $1.00 per share for 30 consecutive business days, prompting the notice. According to Nasdaq rules, the company has 180 calendar days, until November 3, 2025, to regain compliance by ensuring its stock price closes at or above $1.00 per share for at least 10 consecutive business days. NeuroOne is actively monitoring its stock price and exploring options to address the deficiency. If the company fails to meet the requirement within the given timeframe, it may be subject to delisting but could appeal the decision or seek additional time to comply.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250509:nNDLLqhNW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","NMTC"],"gpt_icon":0},{"id":"2533955726","title":"NeuroOne Medical Announces Participation in The D. Boral Capital Inaugural Global Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2533955726","media":"Newsfile","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533955726?lang=en_us&edition=fundamental","pubTime":"2025-05-06 04:01","pubTimestamp":1746475260,"startTime":"0","endTime":"0","summary":"Eden Prairie, Minnesota-- - NeuroOne Medical , today announced its participation in the D. Boral Capital Inaugural Global Conference, taking place May 14, 2025, at The Plaza Hotel in New York City.Ron McClurg, CFO, will be hosting one-on-one meetings on May 14th from 9:00 A.M. to 3:00 P.M. .To register for one-on-one meetings with management at The Plaza Hotel in New York City, interested parties should contact John Perez at jperez@dboralcapital.com.About NeuroOne MedicalNeuroOne Medical Technologies Corporation  is developing and commercializing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders that may improve patient outcomes and reduce procedural costs. The Company may also pursue applications for other areas such as depression, mood disorders, pain, inconti","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/neuroone-medical-announces-participation-d-200100091.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/neuroone-medical-announces-participation-d-200100091.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4590","BK4082","BK4585","BK4144","ET","NMTC","BK4581","BK4588","BK4561"],"gpt_icon":0},{"id":"2533189585","title":"NeuroOne Medical Tech Initiated at Buy by Ladenburg Thalmann","url":"https://stock-news.laohu8.com/highlight/detail?id=2533189585","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533189585?lang=en_us&edition=fundamental","pubTime":"2025-05-05 19:49","pubTimestamp":1746445740,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/NMTC/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 05, 2025 07:49 ET (11:49 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","NMTC"],"gpt_icon":0},{"id":"2533583835","title":"NeuroOne Medical initiated with a Buy at Ladenburg","url":"https://stock-news.laohu8.com/highlight/detail?id=2533583835","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533583835?lang=en_us&edition=fundamental","pubTime":"2025-05-05 19:16","pubTimestamp":1746443793,"startTime":"0","endTime":"0","summary":"Ladenburg initiated coverage of NeuroOne Medical (NMTC) with a Buy rating and $1.45 price target Published first on TheFly – the ultimate source fo...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/neuroone-medical-initiated-with-a-buy-at-ladenburg?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/neuroone-medical-initiated-with-a-buy-at-ladenburg?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","NMTC"],"gpt_icon":0},{"id":"2532749003","title":"Small Business Owners Are Not as Financially Prepared as They May Think, According to TD Bank Survey","url":"https://stock-news.laohu8.com/highlight/detail?id=2532749003","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532749003?lang=en_us&edition=fundamental","pubTime":"2025-05-01 21:30","pubTimestamp":1746106200,"startTime":"0","endTime":"0","summary":"Vast majority (82%) of small business owners indicate that they are likely to consider applying for a loan or line of credit but overlook the value of expert financial advice. \"Now, more than ever, it is critical for business owners to be financially prepared,\" said Andy Bregenzer, Co-Head of U.S. Commercial Banking at TD Bank. \"Business owners who invest the time to create a financial plan will be better positioned to face challenges and seize new opportunities. Financial preparedness is not just about business survival but also about positioning your business to grow with confidence no matter what the future holds.\"","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/small-business-owners-not-financially-133000008.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4585","BK4082","BK4207","NMTC","TD","BK4566"],"gpt_icon":0},{"id":"2529011346","title":"Apogee Enterprises Reports Fiscal 2025 Fourth Quarter and Full Year Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2529011346","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529011346?lang=en_us&edition=fundamental","pubTime":"2025-04-24 18:30","pubTimestamp":1745490600,"startTime":"0","endTime":"0","summary":"Fourth-quarter diluted EPS of $0.11 and adjusted diluted EPS of $0.89. Full-year operating margin of 8.7%; full-year adjusted operating margin improves to 11.0%. Full-year diluted EPS of $3.89; full-year adjusted diluted EPS grows 4% to $4.97. MINNEAPOLIS, April 24, 2025----Apogee Enterprises, Inc.  today reported its fiscal 2025 fourth-quarter and full-year results. The prior year fourth-quarter and full-year results included the impact of an additional week of operations compared to fiscal 2025. The Company reported the following selected financial results:. During the fourth quarter, the Company changed the names of two reporting segments, to better reflect their product focus and capabilities. The previously named Architectural Framing Systems Segment is now referred to as the Architectural Metals Segment. The previously named Large-Scale Optical Segment is now referred to as the Performance Surfaces Segment.Year ended March 1, 2025, compared with the year ended March 2, 2024","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/apogee-enterprises-reports-fiscal-2025-103000717.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4097","H","BK4566","LU1267930227.SGD","A","BK4082","LU1201861249.SGD","LU0162691827.USD","F","ROIC","R","BK4559","BK4208","IE00BD4GTW91.USD","K","LU2462157665.USD","L","BK4022","BK4080","BK4516","BK4231","LU2286300806.USD","J","S","G","IE00BZ18W340.USD","BK4585","BK4574","LU1162221912.USD","D","LU0106831901.USD","IE00BMG7P587.USD","LU1366192091.USD","LU2413666699.HKD","BK4106","LU1165135440.EUR","BK4142","IE00B29SXL02.USD","LU0170899867.USD","LU0310800965.SGD","BK4539","APOG","E","NMTC","LU0477156953.USD","O","IE00B3T34201.USD","IE00BZ18W456.USD"],"gpt_icon":0},{"id":"2529468814","title":"Neuroone® Completes FDA Submission for the Onerf® Trigeminal Nerve Ablation System to Treat Facial Pain","url":"https://stock-news.laohu8.com/highlight/detail?id=2529468814","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529468814?lang=en_us&edition=fundamental","pubTime":"2025-04-23 21:00","pubTimestamp":1745413202,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250423:nTUASC2S4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NMTC","BK4082"],"gpt_icon":0},{"id":"2529953680","title":"NeuroOne® Completes FDA Submission for the OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain","url":"https://stock-news.laohu8.com/highlight/detail?id=2529953680","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529953680?lang=en_us&edition=fundamental","pubTime":"2025-04-23 21:00","pubTimestamp":1745413200,"startTime":"0","endTime":"0","summary":"Multi-Contact Probe Provides Alternative to Pharmaceutical and Invasive Surgical Treatments. EDEN PRAIRIE, Minn., April 23, 2025  -- NeuroOne Medical Technologies Corporation  , a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, has filed its 510 submission to the FDA for trigeminal nerve ablation earlier than previous guidance.Previously published data have shown that RF ablation offers high initial pain relief rates  and long-term efficacy, especially with repeat treatments, while maintaining a low complication rate2,3, These characteristics make it a preferred option for patients who are not candidates for major surgery or who are looking for less invasive approaches4.“If cleared by the FDA, we believe there is a potential to generate revenues from trigeminal nerve ablation in late calendar year 2025.”NeuroOne Medical Technologies Corporation  is developing and commercializing minimally invasive an","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/neuroone-completes-fda-submission-onerf-130000280.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1244550577.SGD","IE00BJJMRY28.SGD","BK4566","LU1244550494.USD","LU1732799900.SGD","LU0417517546.SGD","LU0868494617.USD","BK4588","LU1732800096.USD","IE00BFSS8Q28.SGD","LU1585245621.USD","LU1244550221.USD","LU2347655156.SGD","LU2279689827.SGD","LU1718418525.SGD","LU0256863811.USD","IE0004445015.USD","IE00BJTD4V19.USD","NMTC","IE00BJTD4N35.SGD","BK4209","IE00BFSS7M15.SGD","LU0912757837.SGD","BK4581","BK4585","BK4504","RF","LU0795875169.SGD","BK4534","BK4610","BK4082","IE00B7KXQ091.USD","IE00BJJMRX11.SGD","LU2133065610.SGD","LU0868494708.USD","BK4550","LU0942090050.USD","LU1430594728.SGD","BK4211","LU0795875086.SGD","MCD"],"gpt_icon":0},{"id":"2529813359","title":"NeuroOne Medical Technologies Corp (NMTC) Q1 2025 Earnings Call Highlights: Regulatory Success ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2529813359","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529813359?lang=en_us&edition=fundamental","pubTime":"2025-04-22 05:10","pubTimestamp":1745269804,"startTime":"0","endTime":"0","summary":"For the complete transcript of the earnings call, please refer to the full earnings call transcript.NeuroOne Medical Technologies Corp  has three FDA 510 cleared electrode families, showcasing regulatory success.The company has exclusive partnerships with prestigious organizations like the Mayo Clinic and Zimmer Biomet, enhancing credibility and market reach.Preliminary fiscal Q1 2025 revenues were reported at $6.2 million, with a significant portion from product revenues.A: An exact date can't be provided as training is ongoing, with approximately 150 people to be trained over the next 3-4 months. The good news is that the device is familiar to reps, with the main difference being the ablation component. - David Rosa, CEO","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/neuroone-medical-technologies-corp-nmtc-211004117.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ZBH","NMTC"],"gpt_icon":0},{"id":"2527217133","title":"BRIEF-Neuroone Medical Technologies Corp -Company Now Fully Funded Through At Least Fiscal 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2527217133","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527217133?lang=en_us&edition=fundamental","pubTime":"2025-04-16 21:10","pubTimestamp":1744809001,"startTime":"0","endTime":"0","summary":"BRIEF-Neuroone Medical Technologies Corp -Company Now Fully Funded Through At Least Fiscal 2026April 16 (Reuters) - Neuroone Medical Technologies Corp NMTC.O:NEUROONE MEDICAL TECHNOLOGIES CORP -COMPAN","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250416:nFWN3QU11W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","NMTC"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":59,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NMTC\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-13","symbol":"NMTC","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747108800000,"reportTimeType":"pre","actualEps":-0.07},{"market":"US","date":"2025-02-12","symbol":"NMTC","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1739336400000,"reportTimeType":"pre","actualEps":0.06},{"market":"US","date":"2025-01-10","symbol":"NMTC","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1736485200000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2024-12-17","symbol":"NMTC","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1734411600000,"reportTimeType":"pre","actualEps":-0.11},{"market":"US","date":"2024-08-14","symbol":"NMTC","fiscalQuarterEnding":"2024/06","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723608000000,"reportTimeType":"post","actualEps":-0.1}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NMTC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NMTC\",market:\"US\",delay:false,,,undefined,":{"strongBuy":1,"buy":0,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":1,"analysts":1,"updateTime":1746676800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NMTC\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NMTC","date":"2025-06-06","current":-4.443572,"percent":0.086053,"low":-5.152424,"twenty":-3.692571,"median":-2.348324,"eighty":-2.006664,"high":-1.439522,"avg":-2.707375,"sd":0.928626,"marketCap":29342704},"quantilePoints":[{"date":"2024-01-05","current":-3.152078,"twenty":-3.152078,"median":-3.152078,"eighty":-3.152078,"marketCap":37382041},{"date":"2024-01-12","current":-2.966641,"twenty":-3.158726,"median":-3.134059,"eighty":-3.111667,"marketCap":35182851},{"date":"2024-01-19","current":-2.88127,"twenty":-3.153408,"median":-3.039154,"eighty":-2.915418,"marketCap":34170395},{"date":"2024-01-26","current":-2.689185,"twenty":-3.123248,"median":-2.945298,"eighty":-2.872733,"marketCap":31892369},{"date":"2024-02-02","current":-3.038108,"twenty":-3.112542,"median":-2.923955,"eighty":-2.729733,"marketCap":36030419},{"date":"2024-02-09","current":-2.753969,"twenty":-3.070305,"median":-2.923955,"eighty":-2.729733,"marketCap":32660667},{"date":"2024-02-16","current":-2.021098,"twenty":-3.070305,"median":-2.902613,"eighty":-2.712471,"marketCap":27227472},{"date":"2024-02-23","current":-2.117341,"twenty":-3.046851,"median":-2.859927,"eighty":-2.587856,"marketCap":28524018},{"date":"2024-03-01","current":-2.329075,"twenty":-3.024994,"median":-2.753969,"eighty":-2.198185,"marketCap":31376420},{"date":"2024-03-08","current":-2.406069,"twenty":-2.999291,"median":-2.726527,"eighty":-2.225133,"marketCap":32413657},{"date":"2024-03-15","current":-2.059595,"twenty":-2.985273,"median":-2.710255,"eighty":-2.186636,"marketCap":27746090},{"date":"2024-03-22","current":-2.13659,"twenty":-2.973371,"median":-2.639564,"eighty":-2.13659,"marketCap":28783327},{"date":"2024-03-28","current":-2.319451,"twenty":-2.958104,"median":-2.489984,"eighty":-2.144289,"marketCap":31246765},{"date":"2024-04-05","current":-2.367572,"twenty":-2.936761,"median":-2.388746,"eighty":-2.163538,"marketCap":31895038},{"date":"2024-04-12","current":-2.329075,"twenty":-2.923955,"median":-2.386821,"eighty":-2.182786,"marketCap":31376420},{"date":"2024-04-19","current":-2.194335,"twenty":-2.906881,"median":-2.367572,"eighty":-2.182786,"marketCap":29561255},{"date":"2024-04-26","current":-2.13659,"twenty":-2.88127,"median":-2.348324,"eighty":-2.182786,"marketCap":28783327},{"date":"2024-05-03","current":-2.329075,"twenty":-2.864196,"median":-2.329075,"eighty":-2.175087,"marketCap":31376420},{"date":"2024-05-10","current":-2.232832,"twenty":-2.813481,"median":-2.324263,"eighty":-2.175087,"marketCap":30079874},{"date":"2024-05-17","current":-2.126501,"twenty":-2.767083,"median":-2.308772,"eighty":-2.155838,"marketCap":27227472},{"date":"2024-05-24","current":-2.207511,"twenty":-2.745226,"median":-2.271329,"eighty":-2.155838,"marketCap":28264709},{"date":"2024-05-31","current":-1.914053,"twenty":-2.732064,"median":-2.261705,"eighty":-2.146753,"marketCap":24507318},{"date":"2024-06-07","current":-1.846154,"twenty":-2.729733,"median":-2.252081,"eighty":-2.13659,"marketCap":23637945},{"date":"2024-06-14","current":-2.069476,"twenty":-2.721183,"median":-2.249194,"eighty":-2.126501,"marketCap":26497329},{"date":"2024-06-21","current":-1.804839,"twenty":-2.714657,"median":-2.232832,"eighty":-2.100768,"marketCap":23108945},{"date":"2024-06-28","current":-1.615657,"twenty":-2.712471,"median":-2.232832,"eighty":-2.078218,"marketCap":20686682},{"date":"2024-07-05","current":-1.848329,"twenty":-2.710255,"median":-2.232832,"eighty":-2.069476,"marketCap":23665787},{"date":"2024-07-12","current":-2.022507,"twenty":-2.689185,"median":-2.213584,"eighty":-2.039685,"marketCap":25895940},{"date":"2024-07-15","current":-2.065779,"twenty":-2.682608,"median":-2.213584,"eighty":-2.039817,"marketCap":26449997},{"date":"2024-08-02","current":-1.563469,"twenty":-2.676031,"median":-2.213584,"eighty":-2.030552,"marketCap":20018472},{"date":"2024-08-09","current":-1.611525,"twenty":-2.642911,"median":-2.207511,"eighty":-2.008766,"marketCap":20633782},{"date":"2024-08-16","current":-1.857244,"twenty":-2.587856,"median":-2.194335,"eighty":-1.98032,"marketCap":22477552},{"date":"2024-08-23","current":-2.011247,"twenty":-2.499067,"median":-2.187258,"eighty":-1.978947,"marketCap":24341385},{"date":"2024-08-30","current":-2.060127,"twenty":-2.444567,"median":-2.175087,"eighty":-1.978947,"marketCap":24932973},{"date":"2024-09-06","current":-1.960329,"twenty":-2.436867,"median":-2.155838,"eighty":-1.978799,"marketCap":23725147},{"date":"2024-09-13","current":-2.137268,"twenty":-2.402604,"median":-2.155838,"eighty":-1.978799,"marketCap":25866573},{"date":"2024-09-20","current":-2.380399,"twenty":-2.388361,"median":-2.155838,"eighty":-1.978873,"marketCap":28809107},{"date":"2024-09-27","current":-2.494964,"twenty":-2.436867,"median":-2.155838,"eighty":-1.979855,"marketCap":30195642},{"date":"2024-10-04","current":-2.36767,"twenty":-2.489872,"median":-2.175087,"eighty":-1.985012,"marketCap":28655048},{"date":"2024-10-11","current":-2.316752,"twenty":-2.515331,"median":-2.187258,"eighty":-1.994698,"marketCap":28038810},{"date":"2024-10-18","current":-2.36767,"twenty":-2.489872,"median":-2.194335,"eighty":-1.994929,"marketCap":28655048},{"date":"2024-10-25","current":-2.545627,"twenty":-2.489872,"median":-2.207511,"eighty":-1.996274,"marketCap":30808798},{"date":"2024-10-31","current":-2.507693,"twenty":-2.507693,"median":-2.213584,"eighty":-2.000544,"marketCap":30349701},{"date":"2024-11-08","current":-2.304023,"twenty":-2.494964,"median":-2.218396,"eighty":-2.001063,"marketCap":27884751},{"date":"2024-11-15","current":-1.988334,"twenty":-2.469505,"median":-2.223208,"eighty":-2.001063,"marketCap":24064078},{"date":"2024-11-22","current":-1.781608,"twenty":-2.469505,"median":-2.213584,"eighty":-1.994658,"marketCap":21562153},{"date":"2024-11-29","current":-1.586339,"twenty":-2.449555,"median":-2.210547,"eighty":-1.979094,"marketCap":19198882},{"date":"2024-12-06","current":-1.527529,"twenty":-2.444567,"median":-2.194335,"eighty":-1.954281,"marketCap":18487128},{"date":"2024-12-13","current":-1.94429,"twenty":-2.440892,"median":-2.194335,"eighty":-1.928958,"marketCap":23531032},{"date":"2024-12-20","current":-1.897865,"twenty":-2.422863,"median":-2.186912,"eighty":-1.922356,"marketCap":23378107},{"date":"2024-12-27","current":-2.155754,"twenty":-2.418434,"median":-2.175087,"eighty":-1.92028,"marketCap":26554815},{"date":"2025-01-03","current":-2.065117,"twenty":-2.413427,"median":-2.155838,"eighty":-1.925043,"marketCap":25438341},{"date":"2025-01-10","current":-2.704082,"twenty":-2.435695,"median":-2.175087,"eighty":-1.92625,"marketCap":33309176},{"date":"2025-01-17","current":-2.604181,"twenty":-2.469505,"median":-2.187085,"eighty":-1.927409,"marketCap":32078587},{"date":"2025-01-24","current":-2.804233,"twenty":-2.520423,"median":-2.194335,"eighty":-1.927409,"marketCap":34542849},{"date":"2025-01-31","current":-2.879346,"twenty":-2.5354,"median":-2.194335,"eighty":-1.93009,"marketCap":35468104},{"date":"2025-02-07","current":-2.485752,"twenty":-2.545627,"median":-2.210547,"eighty":-1.935379,"marketCap":30619768},{"date":"2025-02-14","current":-4.894803,"twenty":-2.57134,"median":-2.213584,"eighty":-1.94429,"marketCap":35183297},{"date":"2025-02-21","current":-4.80893,"twenty":-2.603981,"median":-2.223208,"eighty":-1.957121,"marketCap":34566047},{"date":"2025-02-28","current":-4.76771,"twenty":-2.660149,"median":-2.232832,"eighty":-1.960736,"marketCap":34269766},{"date":"2025-03-07","current":-4.379561,"twenty":-2.704082,"median":-2.232832,"eighty":-1.97462,"marketCap":31479792},{"date":"2025-03-14","current":-4.379561,"twenty":-2.72277,"median":-2.250637,"eighty":-1.978652,"marketCap":31479792},{"date":"2025-03-21","current":-4.293687,"twenty":-2.758113,"median":-2.252081,"eighty":-1.978799,"marketCap":30862542},{"date":"2025-03-28","current":-3.872906,"twenty":-2.809841,"median":-2.265835,"eighty":-1.979094,"marketCap":27838012},{"date":"2025-04-04","current":-3.692571,"twenty":-2.879346,"median":-2.271329,"eighty":-1.981914,"marketCap":26541786},{"date":"2025-04-11","current":-2.836056,"twenty":-2.879346,"median":-2.271329,"eighty":-1.981914,"marketCap":20385253},{"date":"2025-04-17","current":-3.722076,"twenty":-2.88127,"median":-2.290936,"eighty":-1.986041,"marketCap":26753867},{"date":"2025-04-25","current":-3.978521,"twenty":-2.932492,"median":-2.304023,"eighty":-1.992128,"marketCap":28597164},{"date":"2025-05-02","current":-4.074111,"twenty":-2.989597,"median":-2.313162,"eighty":-1.994779,"marketCap":29284255},{"date":"2025-05-09","current":-4.022031,"twenty":-3.032987,"median":-2.319451,"eighty":-1.995068,"marketCap":28909909},{"date":"2025-05-16","current":-4.707405,"twenty":-3.103727,"median":-2.329075,"eighty":-1.998409,"marketCap":31084905},{"date":"2025-05-23","current":-4.420369,"twenty":-3.162936,"median":-2.332028,"eighty":-2.000855,"marketCap":29189484},{"date":"2025-05-30","current":-4.580392,"twenty":-3.547773,"median":-2.342211,"eighty":-2.002081,"marketCap":30246181},{"date":"2025-06-06","current":-4.443572,"twenty":-3.692571,"median":-2.348324,"eighty":-2.006664,"marketCap":29342704}],"updateTime":1749535683136}}}